Data coverage, completeness and provenance for PRESCIENT THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0530 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0550 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0520 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0540 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0510 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/PTX/prices · Price parameters and adjustment semantics
Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first-in-class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of the enzyme GGT-1. The company is also developing cell therapy platforms, including CellPryme, a high-performance cell therapy enhancement platform; and OmniCAR, is a platform seeks to overcome the challenges of conventional CAR-T therapy including manufacturing, safety and reliability. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.
Website: https://ptxtherapeutics.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/PTX/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 25 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 23 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 24 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 23 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/PTX
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/PTX/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/PTX/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/PTX/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/PTX/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/PTX
Free tier — instant API key. Built for AI agents.